This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2003-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 834,570 Years Active: 2003-2010
Title: Miroslaw F Stranc: Innovator in Tissue Viability Assessment
Introduction
Miroslaw F Stranc is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of medical technology, particularly in assessing tissue viability using advanced techniques.
Latest Patents
Stranc holds 2 patents, with his latest innovations focusing on the method of assessing tissue viability using near-infrared spectroscopy. His research demonstrates the potential of this technology for predicting the viability of compromised tissue portions. The method clearly identifies tissue regions with low oxygen supply and assesses the severity of this challenge in a rapid and non-invasive manner. This approach has a high degree of reproducibility, which is crucial for clinical applications. Early detection of poor tissue oxygenation following surgery increases the likelihood of successful interventions aimed at saving the tissue.
Career Highlights
Throughout his career, Stranc has focused on the intersection of technology and medicine. His work has provided valuable insights into the monitoring of tissue oxygenation status and the assessment of tissue viability following reconstructive surgery. The findings from his patents indicate that tissues remaining below a certain hemoglobin oxygen saturation threshold for prolonged periods become increasingly dehydrated and may eventually become necrotic. Conversely, tissues above this threshold, despite being hypoxic, remain viable over extended monitoring periods.
Collaborations
Stranc has collaborated with esteemed colleagues, including Michael G Sowa and Henry H Mantsch. Their combined expertise has contributed to the advancement of research in tissue viability and medical imaging.
Conclusion
Miroslaw F Stranc's innovative work in assessing tissue viability through near-infrared spectroscopy represents a significant advancement in medical technology. His contributions have the potential to improve surgical outcomes and enhance patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile